Hematologic Malignancies: ASCO Meeting Highlights New Approaches To Treatment
Studies Test New Agents Offering Relief From Treatment-Related Side Effects
Oral UFT Equivalent To FULV In Stage II and III Colon Cancer
Adjuvant Chemo Improves Survival In Early Lung Cancer
Treat Cancer, But Protect Heart Anderson Cardiologists Warn
NCI-Approved Clinical Trials
Trending Stories
- Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.” - Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Cancer Center at Illinois is recognized as NCI Basic Cancer Center, becoming the first new institution to earn this designation in 40 years
- Most Favored Nation drug pricing could put China on top
- Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
- Self-collection kits for HPV are among innovations adding momentum to eradication of cervical cancer
A kit for at-home unsupervised self-collection clears FDA finish line









